Sirolimus-Eluting Stent Implantation Aggravates Endothelial Vasomotor Dysfunction in the Infarct-Related Coronary Artery in Patients With Acute Myocardial Infarction

Journal of the American College of Cardiology

Volumn 50, Issue 14, 2007, Pages 1305-1309

  Obata, Jyun ei ^a   Kitta, Yoshinobu ^a   Takano, Hajime ^a   Kodama, Yasushi ^a   Nakamura, Takamitsu ^a   Mende, Akira ^a   Kawabata, Ken ichi ^a   Saitoh, Yukio ^a   Fujioka, Daisuke ^a   Kobayashi, Tsuyoshi ^a   Yano, Toshiaki ^a   Kugiyama, Kiyotaka ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; NITRATE; NITROPRUSSIDE SODIUM; RAPAMYCIN; TICLOPIDINE; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ACTIVITY; DRUG ELUTING STENT; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; REPERFUSION; VASOMOTOR DISORDER;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY STENOSIS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SIROLIMUS; STENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOMOTOR SYSTEM;

EID: 34548819010     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.06.031     Document Type: Article

References (13)

1. Ku D.D. Coronary vascular reactivity after myocardial ischemia. Science 218 (1982) 576-578
2. Yamamuro A., Akasaka T., Tamita K., et al. Coronary flow velocity pattern immediately after percutaneous coronary intervention as a predictor of complications and in-hospital survival after acute myocardial infarction. Circulation 106 (2002) 3051-3056
3. Lee S.H., Wolf P.L., Escudero R., et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342 (2000) 626-633
4. Matsunaga T., Warltier D.C., Weihrauch D.W., et al. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102 (2000) 3098-3103
5. Luo Z., Diaco M., Murohara T., et al. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 64 (1997) 993-998
6. Moses J.W., Leon M.B., Popma J.J., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
7. Togni M., Windecker S., Cocchia R., et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46 (2005) 231-236
8. Hofma S.H., van der Giessen W.J., van Dalen B.M., et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 166-170
9. Guba M., von Breitenbuch P., Steinbauer M., et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8 (2002) 128-135
10. Takano H., Kodama Y., Kitta Y., et al. Transcardiac adiponectin gradient is independently related to endothelial vasomotor function in large and resistance coronary arteries in humans. Am J Physiol Heart Circ Physiol 291 (2006) H2641-H2646
11. Vetrovec G.W., Rizik D., Williard C., et al. Sirolimus PK trial: a pharmacokinetic study of the sirolimus-eluting Bx Velocity stent in patients with de novo coronary lesions. Catheter Cardiovasc Interv 67 (2006) 32-37
12. Ramzy D., Rao V., Tumiati L.C., et al. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury. Comparative effects of rapamycin and cyclosporine. Circulation 114 Suppl I (2006) 214-219
13. Long C., Cook L.G., Hamilton S.L., et al. FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. Hypertension 49 (2007) 569-576